本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

12.49
+0.37003.05%
盘后12.490.00000.00%16:37 EDT
成交量:139.50万
成交额:1,743.19万
市值:16.69亿
市盈率:-6.85
高:12.87
开:12.14
低:11.91
收:12.12
数据加载中...
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities